Multisorb to Build New Manufacturing Facility in India
The company announced that it will build a new manufacturing facility at the GMR Aerospace Park at the Rajiv Gandhi International Airport in India.
On Oct. 4, 2016, Multisorb Technologies announced the construction of a new manufacturing facility in Hyderabad, Telangana, India. The new facility, made via foreign direct investment, will be located in the GMR Aerospace Park at the Rajiv Gandhi International Airport approximately 25 kilometers south of Hyderabad city center.
Approximately 4000 square meters in size, the facility will house Multisorb’s manufacturing processes in a cleanroom environment. The facility will be compliant to US FDA’s CGMP standards (21 CFR Parts 210-211). Laxmikant Khaitan, general manager of Multisorb Technologies India Pvt. Ltd., will lead the new Hyderabad site.
Multisorb plans to manufacture its DMF-supported products in its Hyderabad facility including StripPax desiccant/sorbent packets, IntelliSorb moisture regulating packets, and StabilOx oxygen absorbing packets. It expects to host customer quality system audits of the site during Q4-2017 and begin supplying Indian customers from the Hyderabad site in early Q1-2018.
Source: Multisorb
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
Trump Directs FDA, EPA to Reduce Regulatory Barriers to Domestic Pharma Manufacturing
May 7th 2025The White House is instructing FDA to increase fees for and inspections of foreign drug manufacturing plants and reduce the time required to approve such sites that will be newly constructed in the US.
